Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease. Some researchers have ...
6 hours ago
0
6
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026. Clinical trials showed close to 100% efficacy. The rollout, ...
Jun 1, 2026
0
3
Over half of the people carrying HIV experience chronic pain at some point, which is difficult to treat. In a new JNeurosci paper, Hui-Lin Pan, from The University of Texas MD Anderson Cancer Center, and colleagues used mice ...
Jun 1, 2026
0
4
For many people living with HIV, today's treatments can suppress the virus and dramatically improve health. But even when HIV is controlled, damage to the gut caused by the disease can persist, fueling chronic inflammation ...
May 25, 2026
0
17
In stigmatized illnesses such as human immunodeficiency virus (HIV), shame and other negative self-conscious emotions are associated with suboptimal engagement in health care via stress and avoidance coping. However, shame ...
May 20, 2026
0
2
A study has found that adolescents who were aware of their state's minor consent laws were more likely to seek and receive testing for HIV and other sexually transmitted infections, suggesting that teens' accurate knowledge ...
May 18, 2026
0
2
Advances in HIV treatment have transformed what was once a fatal diagnosis into a manageable chronic condition. Today, children living with HIV are surviving—and increasingly thriving—into adolescence and adulthood.
May 13, 2026
0
4
Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells.
May 12, 2026
0
6
Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily doses of antiretroviral drugs. In one recent clinical study of bNAbs identified ...
May 12, 2026
0
13
A clinical trial conducted in Tanzania and Mozambique and published in The Lancet Infectious Diseases concludes that expanding the use of molecular diagnostic tests on urine and stool samples, in addition to sputum, to detect ...
May 8, 2026
0
3
